Skip to main navigation Skip to search Skip to main content

Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases

Research output: Contribution to journalReview articlepeer-review

114 Citations (Scopus)

Abstract

Neurodegenerative disorders are becoming prevalent with the increasing age of the general population. A number of difficulties have emerged for the potential treatment of neurodegenerative diseases, as these disorders may be multi systemic in nature. Due to limitations regarding the blood brain barrier (BBB) structure, efflux pumps and metabolic enzyme expression, conventional drug delivery systems do not provide efficient therapy for neurodegenerative disorders. Nanotechnology can offer impressive improvement of the neurodegenerative disease treatment by using bio-engineered systems interacting with biological systems at a molecular level. This review focuses on the nano-enabled system applications for the treatment and diagnosis of neurodegenerative diseases, in particular Alzheimer's, Parkinson's and Prion diseases.

Original languageEnglish
Pages (from-to)2499-2511
Number of pages13
JournalPharmaceutical Research
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 2013

Keywords

  • blood brain barrier
  • nano-enabled delivery systems
  • nanotechnology
  • neurodegenerative diseases

Fingerprint

Dive into the research topics of 'Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this